Whitehouse Centers for Disease Control and Prevention US Department of Homeland Security - Federal Emergency Management Agency

Will there be drug shortages due COVID-19?

The FDA has been closely monitoring the supply chain with the expectation that the COVID-19 outbreak would likely impact the medical product supply chain, including potential disruptions to supply or shortages of critical medical products in the U.S.

We have been reaching out to manufacturers as part of our approach to identifying potential disruptions or shortages. We will use all available tools to react swiftly and mitigate the impact to U.S. patients and health care professionals when a potential disruption or shortage is identified.

Find real-time information about drug shortages.

Learn more in our drug shortages frequently asked questions.

Last updated October 16, 2020
Source: U.S. Food & Drug Administrationlinks to external site

See also: Food and drug safety